10.1074/jbc.RA119.011463 43 KurtovicS.ShokeerA.MannervikB
Epub 2013 Jul 1
Clinical trials have demonstrated reductions in HbA1c (a measure of average blood glucose over three months) with semaglutide treatment, with improvements varying based on baseline levels and dose
What Retatrutide actually is Retatrutide is the laboratory designation for Eli Lilly's investigational triple-receptor agonist LY3437943
(Wegovy, Mounjaro & the New Pill, 2026) Updated 22/06/26 Based on the available clinical evidence, Mounjaro (tirzepatide) and Wegovy (semaglutide) are both well tolerated, but most people find Mounjaro causes fewer gastrointestinal side effects at comparable doses, with lower rates of nausea and a higher likelihood of completing treatment
In fact, decades of research show that people taking GLP-1 medications may be more prone to dehydration, especially when intake drops or side effects make it harder to eat and drink enough (2,3)